Two Sigma Advisers’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,619
| Closed | -$187K | – | 2506 |
|
|
2023
Q3 | $187K | Buy |
+4,619
| New | +$187K | ﹤0.01% | 2110 |
|
|
2023
Q2 | – | Sell |
-3,588
| Closed | -$1.07M | – | 2405 |
|
|
2023
Q1 | $1.07M | Buy |
3,588
+1,750
| +95% | +$522K | ﹤0.01% | 1593 |
|
|
2022
Q4 | $632K | Sell |
1,838
-2,206
| -55% | -$758K | ﹤0.01% | 1781 |
|
|
2022
Q3 | $765K | Sell |
4,044
-2,156
| -35% | -$408K | ﹤0.01% | 1657 |
|
|
2022
Q2 | $1.31M | Buy |
6,200
+5,294
| +584% | +$1.12M | ﹤0.01% | 1451 |
|
|
2022
Q1 | $303K | Buy |
906
+100
| +12% | +$33.4K | ﹤0.01% | 2217 |
|
|
2021
Q4 | $262K | Sell |
806
-1,525
| -65% | -$496K | ﹤0.01% | 2184 |
|
|
2021
Q3 | $1.13M | Sell |
2,331
-1,744
| -43% | -$847K | ﹤0.01% | 1555 |
|
|
2021
Q2 | $1.9M | Sell |
4,075
-931
| -19% | -$433K | 0.01% | 1318 |
|
|
2021
Q1 | $3.46M | Buy |
5,006
+3,831
| +326% | +$2.65M | 0.01% | 1019 |
|
|
2020
Q4 | $869K | Buy |
+1,175
| New | +$869K | ﹤0.01% | 1632 |
|
|
2020
Q3 | – | Sell |
-1,700
| Closed | -$1.44M | – | 2411 |
|
|
2020
Q2 | $1.44M | Buy |
+1,700
| New | +$1.44M | ﹤0.01% | 1394 |
|